Results 1 to 10 of about 48,974 (212)

Markers of Biological Aging and Survival in Recurrent and Metastatic Head and Neck Cancer Patients Receiving Immunotherapy. [PDF]

Epigenomes
Nannini DR, Haque I, Banerjee SK, Kambhampati S.   +3 more
europepmc   +1 more source

Beyond reduced intake: tumor metabolism and immune dysregulation drive cancer-related malnutrition in head and neck squamous cell carcinoma (HNSCC). [PDF]

Support Care Cancer
Zurlo V, Piccirillo A, Marciano ML, Pontone M, Rampetta FR, Perri E, Perri F.   +6 more
europepmc   +1 more source

The emerging landscape for next-generation HNSCC treatment. [PDF]

Trends Pharmacol Sci
Jackett KN, Katerji M, Arnold K, Burkitt K, Gennaro A, Saloura V, Brognard J.   +6 more
europepmc   +1 more source

Decoding the role of cancer-associated fibroblasts in cisplatin resistance of head and neck squamous cell carcinoma. [PDF]

iScience
Liu D, Yu D, Chen M, Dai T, Li X, Su D, Zheng J, Zhang Y.   +7 more
europepmc   +1 more source

IL-1α Expands SLC2A1highSPP1highIFNlow Myeloid Cells to Drive Immune Escape and Malignant Transformation of Precancers. [PDF]

Cancer Res
Taner H, Gong W, Lanzel EA, Debnath KC, Nör F, Okuyama K, Wu Y, Ursin CA, Islam S, Hu X, He Y, Fitzsimonds ZR, Li Z, Kuczura JM, Rajesh S, Manousidaki A, Feng S, Lee M, Demehri S, Wen H, Sikora AG, Chambers MS, Myers JN, Polverini PJ, Nör JE, Young S, Wang TD, Que J, Hu J, Xie Y, Moon JJ, Lei YL.   +31 more
europepmc   +1 more source

Single-cell spatial transcriptomics identifies SERPINE1 as a vascular endothelial mediator of cisplatin resistance in head and neck squamous cell carcinoma. [PDF]

Transl Oncol
Su H, Zhang Y, Wang J, Liu L, Zhao Y.
europepmc   +1 more source

A Hypoxia Associated STC2 High Endothelial Subpopulation is Linked to Lipid Metabolic Reprogramming, Pathological Angiogenesis, and Immune Remodeling in Head and Neck Squamous Cell Carcinoma. [PDF]

Int J Gen Med
Chen K, Qin L, Liu Z, Zhu J, Li J, Qiu T, Xu S, Ying K, Zhu L, Wang F, Sun M.   +10 more
europepmc   +1 more source

Prognostic Value of FST and Relevance to Immune Infiltration in Head and Neck Squamous Cell Carcinoma. [PDF]

World J Otorhinolaryngol Head Neck Surg
Song P, Wu TW, Wang JY, Ye YC, Liang FY, Huang XM, Han P.   +6 more
europepmc   +1 more source

Digital Twins for Targeted Therapy in Head and Neck Cancer: From Molecular Stratification to Resistance-Aware Combination Strategies. [PDF]

Curr Oncol
Gonçalves F, Gonçalves M, Barata P, Vale N.   +3 more
europepmc   +1 more source

The efficacy of concurrent chemoradiotherapy with or without nimotuzumab in high-risk patients with locally advanced head and neck squamous cell carcinoma post-surgery: A real-world study. [PDF]

Precis Radiat Oncol
Zhou Y, Zhang L, Lai W, Tan J, Gao J, Liu Y, Wang S, Peng F, Tong G.   +8 more
europepmc   +1 more source